Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, Bush RL, Blebea J, Carpentier PH, De Maeseneer M, Gasparis A, Labropoulos N, Marston WA, Rafetto J, Santiago F, Shortell C, Uhl JF, Urbanek T, van Rij A, Eklof B, Gloviczki P, Kistner R, Lawrence P, Moneta G, Padberg F, Perrin M, Wakefield T, et al.
Journal of vascular surgery. Venous and lymphatic disorders. Date of publication 2020 May 1;volume 8(3):342-352.
1. J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):342-352. doi:
10.1016/j.jvsv.2019.12.075. Epub 2020 Feb 27.
The 2020 update of the CEAP classification system and reporting standards.
Lurie F(1), Passman M(2), Meisner M(3), Dalsing M(4), Masuda E(5), Welch H(6),
Bush RL(7), Blebea J(8), Carpentier PH(9), De Maeseneer M(10), Gasparis A(11),
Labropoulos N(11), Marston WA(12), Rafetto J(13), Santiago F(14), Shortell C(15),
Uhl JF(16), Urbanek T(17), van Rij A(18), Eklof B(5), Gloviczki P(19), Kistner
R(5), Lawrence P(20), Moneta G(21), Padberg F(22), Perrin M(23), Wakefield T(24).
Author information:
(1)Jobst Vascular Institute, Toledo, Ohio; Division of Vascular Surgery,
University of Michigan, Ann Arbor, Mich. Electronic address:
fedor.lurie@promedica.org.
(2)Department of Surgery, University of Alabama at Birmingham, Birmingham, Ala.
(3)Department of Surgery, University of Washington School of Medicine, Seattle,
Wash.
(4)Department of Surgery, Indiana University School of Medicine, Indianapolis,
Ind.
(5)Department of Surgery, University of Hawaii, Honolulu, Hi.
(6)Vascular Surgery, Lahey Hospital and Medical Center, Burlington, Mass.
(7)University of Houston College of Medicine, Houston, Tex.
(8)Department of Surgery, Central Michigan University College of Medicine,
Saginaw, Mich.
(9)Grenoble University Hospital, Grenoble, France.
(10)Erasmus MC, Rotterdam, The Netherlands.
(11)Center for Vein Care, Stony Brook University, Stony Brook, NY.
(12)Department of Surgery, University of North Carolina School of Medicine,
Chapel Hill, NC.
(13)Harvard Medical School, Uniformed Services University of the Health Sciences,
VA Boston HCS, Brigham and Women's Hospital, Boston, Mass.
(14)Venous and Lymphatics Disease Institute, Goiania, Brazil.
(15)Department of Surgery, Duke University Medical Center, Durham, NC.
(16)Paris Descartes University, Paris, France.
(17)Medical University of Silesia, Katowice, Poland.
(18)Dunedin School of Medicine, University of Otago, Otago, New Zealand.
(19)Vascular Surgery, Mayo Clinic, Rochester, Minn.
(20)University of California, Los Angeles, Calif.
(21)Oregon Health & Science University, Portland, Ore.
(22)Rutgers New Jersey Medical School, Newark, NJ.
(23)Service de Chirurgie Vasculaire, Clinique du Grand Large, Décines, France.
(24)Division of Vascular Surgery, University of Michigan, Ann Arbor, Mich.
Erratum in
J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):288.
Comment in
Phlebology. 2020 Dec;35(10):745-748.
The CEAP (Clinical-Etiology-Anatomy-Pathophysiology) classification is an
internationally accepted standard for describing patients with chronic venous
disorders and it has been used for reporting clinical research findings in
scientific journals. Developed in 1993, updated in 1996, and revised in 2004,
CEAP is a classification system based on clinical manifestations of chronic
venous disorders, on current understanding of the etiology, the involved anatomy,
and the underlying venous pathology. As the evidence related to these aspects of
venous disorders, and specifically of chronic venous diseases (CVD, C2-C6)
continue to develop, the CEAP classification needs periodic analysis and
revisions. In May of 2017, the American Venous Forum created a CEAP Task Force
and charged it to critically analyze the current classification system and
recommend revisions, where needed. Guided by four basic principles (preservation
of the reproducibility of CEAP, compatibility with prior versions,
evidence-based, and practical for clinical use), the Task Force has adopted the
revised Delphi process and made several changes. These changes include adding
Corona phlebectatica as the C4c clinical subclass, introducing the modifier "r"
for recurrent varicose veins and recurrent venous ulcers, and replacing numeric
descriptions of the venous segments by their common abbreviations. This report
describes all these revisions and the rationale for making these changes.
Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc. All
rights reserved.
DOI: 10.1016/j.jvsv.2019.12.075
PMID: 32113854 [Indexed for MEDLINE]
